| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |